-+ 0.00%
-+ 0.00%
-+ 0.00%

$2.9 MILLION NCI GRANT AWARDED FOR CLINICAL DEVELOPMENT OF REDHILL'S OPAGANIB AND CAR T-CELL COMBINATION IN ULTRA-HIGH-RISK MULTIPLE MYELOMA

Reuters·10/19/2026 12:02:09